Complete Filing Data
PepGen Inc. reported Stockholders Equity of $147.44 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean PepGen Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Net Income Loss | -$89.7M | -$90.0M | -$78.6M | -$69.1M | -$27.3M |
| Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | -$50.0K | $104.0K | -$98.0K | $25.0K | |
| Research And Development Expense | $71.0M | $76.5M | $68.1M | $54.1M | $19.0M |
| Other Nonoperating Income Expense | -$11.0K | -$1.0K | -$187.0K | $110.0K | -$172.0K |
| Operating Income Loss | -$93.6M | -$97.7M | -$84.8M | -$68.3M | -$27.1M |
| Operating Expenses | $93.6M | $97.7M | $84.8M | $68.3M | $27.1M |
| Nonoperating Income Expense | $4.0M | $7.1M | $6.2M | $2.9M | -$172.0K |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$89.6M | -$90.6M | -$78.6M | -$65.4M | -$27.3M |
| General And Administrative Expense | $22.6M | $21.3M | $16.6M | $14.2M | $8.1M |
| Comprehensive Income Net Of Tax | -$89.7M | -$90.0M | -$78.5M | -$69.2M | -$27.3M |
| Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent | $0.00 | -$50.0K | $104.0K | -$98.0K | $25.0K |
| Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | -$12.0K | $39.0K | $11.0K | ||
| Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax | -$12.0K | $39.0K | $11.0K | ||
| Income Tax Expense Benefit | $48.9K | -$617.0K | $73.0K | $3.7M | $0.00 |
| Income Taxes Paid Net | $82.0K | $71.0K | $2.7M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income Loss | -$18.0M | -$23.1M | -$30.2M | -$21.4M | -$28.3M | -$18.0M | -$23.3M | -$19.5M | -$16.3M | -$18.6M | -$17.3M | -$18.2M | -$8.1M | -$5.4M | -$6.6M |
| Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | -$1.0K | -$20.0K | -$1.0K | -$51.0K | -$70.0K | $41.0K | $53.0K | -$31.0K | -$42.0K | -$74.0K | $3.0K | -$3.0K | $26.0K | ||
| Research And Development Expense | $13.4M | $18.4M | $25.4M | $17.7M | $25.1M | $14.7M | $20.5M | $16.9M | $14.4M | $16.0M | $14.2M | $10.7M | $5.7M | $3.2M | $5.5M |
| Other Nonoperating Income Expense | -$6.0K | $3.0K | -$3.0K | -$39.0K | -$31.0K | $43.0K | -$88.0K | -$62.0K | -$80.0K | $4.0K | $76.0K | $58.0K | -$34.0K | -$197.0K | -$8.0K |
| Operating Income Loss | -$18.7M | -$23.9M | -$31.3M | -$23.2M | -$30.4M | -$19.8M | -$24.8M | -$21.1M | -$18.0M | -$19.6M | -$17.6M | -$13.9M | -$8.1M | -$5.2M | -$6.6M |
| Operating Expenses | $18.7M | $23.9M | $31.3M | $23.2M | $30.4M | $19.8M | $24.8M | $21.1M | $18.0M | $19.6M | $17.6M | $13.9M | $8.1M | $5.2M | $6.6M |
| Nonoperating Income Expense | $628.0K | $845.0K | $1.1M | $1.8M | $2.1M | $1.8M | $1.5M | $1.6M | $1.7M | $947.0K | $326.0K | $67.0K | -$34.0K | -$197.0K | -$8.0K |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$18.0M | -$23.1M | -$30.2M | -$21.4M | -$28.3M | -$18.0M | -$23.3M | -$19.5M | -$16.3M | -$18.6M | -$17.3M | -$13.8M | -$8.1M | -$5.4M | -$6.6M |
| General And Administrative Expense | $5.2M | $5.5M | $5.9M | $5.4M | $5.4M | $5.1M | $4.2M | $4.2M | $3.7M | $3.6M | $3.4M | $3.2M | $2.4M | $2.0M | $1.1M |
| Comprehensive Income Net Of Tax | -$18.0M | -$23.1M | -$30.2M | -$21.2M | -$28.4M | -$18.1M | -$23.4M | -$19.5M | -$16.3M | -$18.6M | -$17.4M | -$18.3M | -$8.1M | -$5.4M | -$6.6M |
| Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent | -$1.0K | -$20.0K | -$1.0K | -$51.0K | -$70.0K | $41.0K | $53.0K | -$31.0K | -$42.0K | -$74.0K | $3.0K | -$3.0K | $26.0K | ||
| Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | $18.0K | -$21.0K | -$44.0K | $186.0K | -$37.0K | -$20.0K | |||||||||
| Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax | $18.0K | -$21.0K | -$44.0K | $186.0K | -$37.0K | -$20.0K | |||||||||
| Income Tax Expense Benefit | $4.4M | ||||||||||||||
| Income Taxes Paid Net | $86.0K | $0.00 |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Stockholders Equity | $147.4M | $118.6M | $108.4M | $179.6M | -$32.1M | -$6.4M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $62.1M | $51.0M | $82.3M | $183.2M | $134.4M | $9.8M |
| Cash And Cash Equivalents At Carrying Value | $60.5M | $49.4M | $80.8M | $181.8M | $132.9M | |
| Retained Earnings Accumulated Deficit | -$361.1M | -$271.5M | -$181.5M | -$102.9M | -$33.8M | |
| Property Plant And Equipment Net | $1.9M | $3.7M | $4.8M | $3.3M | $636.0K | |
| Prepaid Expense And Other Assets Current | $2.5M | $3.6M | $2.3M | $4.3M | $2.3M | |
| Other Assets Noncurrent | $372.0K | $426.0K | $442.0K | $1.5M | $3.0M | |
| Liabilities Current | $12.6M | $16.7M | $17.5M | $18.8M | $10.3M | |
| Liabilities And Stockholders Equity | $173.9M | $150.9M | $143.1M | $217.4M | $143.6M | |
| Liabilities | $26.5M | $32.3M | $34.6M | $37.8M | $10.5M | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $11.1M | -$31.4M | -$100.9M | $48.9M | $124.6M | |
| Assets Current | $151.0M | $123.8M | $112.7M | $186.1M | $140.0M | |
| Assets | $173.9M | $150.9M | $143.1M | $217.4M | $143.6M | |
| Additional Paid In Capital Common Stock | $508.5M | $390.1M | $289.9M | $282.6M | $1.7M | |
| Accumulated Other Comprehensive Income Loss Net Of Tax | $11.0K | $23.0K | $34.0K | -$81.0K | $17.0K | |
| Accrued Liabilities Current | $8.6M | $11.9M | $13.5M | $11.9M | $7.1M | |
| Accounts Payable Current | $822.0K | $1.8M | $1.0M | $1.4M | $3.2M | |
| Restricted Cash | $1.5M | $1.5M | $1.5M | $1.5M | $1.5M | |
| Property And Equipment Included In Accounts Payable And Accrued Expenses | $20.0K | $31.0K | $14.0K | $363.0K | ||
| Common Stock Value | $7.0K | $3.0K | $2.0K | $2.0K | ||
| Operating Lease Right Of Use Asset | $19.1M | $21.4M | $23.6M | $26.5M | ||
| Operating Lease Liability Noncurrent | $13.8M | $15.6M | $17.1M | $19.0M | ||
| Operating Lease Liability Current | $3.2M | $3.1M | $3.0M | $5.6M | ||
| Amortization And Interest Accretion Related To Operating Leases | $3.7M | $3.7M | -$334.0K | |||
| Marketable Securities Current | $87.9M | $70.8M | $29.6M | $0.00 | ||
| Deferred Offering Costs In Accounts Payable And Accrued Expenses | $55.0K | $160.0K | ||||
| Restricted Cash Noncurrent | $1.5M | $1.5M | $1.5M | |||
| Other Receivables Net Current | $58.0K | $4.7M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $163.1M | $71.2M | $91.8M | $137.5M | $155.0M | $179.0M | $125.9M | $147.3M | $164.8M | $192.9M | $210.2M | -$49.6M | -$25.6M | -$17.8M | -$12.8M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $144.3M | $36.6M | $45.2M | $43.8M | $67.6M | $135.4M | $131.1M | $148.6M | $166.9M | $197.3M | $220.3M | $120.3M | $141.5M | $16.3M | $6.7M |
| Cash And Cash Equivalents At Carrying Value | $142.8M | $35.1M | $43.6M | $42.3M | $66.1M | $133.9M | $129.5M | $147.0M | $165.4M | $195.8M | $218.8M | $118.9M | $141.5M | $16.3M | $6.7M |
| Retained Earnings Accumulated Deficit | -$342.8M | -$324.8M | -$301.7M | -$249.2M | -$227.8M | -$199.5M | -$162.0M | -$138.7M | -$119.2M | -$87.9M | -$69.3M | -$52.0M | |||
| Property Plant And Equipment Net | $2.2M | $2.5M | $3.5M | $3.9M | $4.2M | $4.4M | $5.0M | $5.3M | $5.3M | $2.7M | $2.8M | $2.6M | |||
| Prepaid Expense And Other Assets Current | $2.5M | $2.8M | $3.3M | $3.5M | $3.5M | $2.4M | $3.6M | $3.4M | $3.1M | $4.6M | $3.4M | $2.2M | |||
| Other Assets Noncurrent | $372.0K | $426.0K | $426.0K | $426.0K | $2.0M | $1.9M | $2.0M | $1.7M | $1.5M | $1.5M | $1.5M | $3.6M | |||
| Liabilities Current | $12.6M | $16.4M | $20.4M | $16.8M | $22.1M | $11.3M | $21.0M | $16.9M | $18.0M | $15.5M | $20.6M | $16.1M | |||
| Liabilities And Stockholders Equity | $190.1M | $102.2M | $127.4M | $170.2M | $193.5M | $207.0M | $164.3M | $182.1M | $201.0M | $208.5M | $230.8M | $131.9M | |||
| Liabilities | $26.9M | $31.1M | $35.6M | $32.8M | $38.5M | $28.0M | $38.4M | $34.8M | $36.2M | $15.5M | $20.6M | $16.3M | |||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$5.8M | $53.1M | -$16.3M | -$14.0M | -$3.1M | ||||||||||
| Assets Current | $166.2M | $77.5M | $101.0M | $142.4M | $164.8M | $177.6M | $133.1M | $150.4M | $168.5M | $204.2M | $226.5M | $125.7M | |||
| Assets | $190.1M | $102.2M | $127.4M | $170.2M | $193.5M | $207.0M | $164.3M | $182.1M | $201.0M | $208.5M | $230.8M | $131.9M | |||
| Additional Paid In Capital Common Stock | $505.9M | $396.0M | $393.5M | $386.6M | $382.9M | $378.5M | $287.9M | $286.0M | $284.0M | $281.0M | $279.6M | $2.5M | |||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -$25.0K | -$43.0K | -$22.0K | $91.0K | -$75.0K | -$37.0K | -$57.0K | $13.0K | -$28.0K | -$130.0K | -$99.0K | -$57.0K | |||
| Accrued Liabilities Current | $8.7M | $12.4M | $14.6M | $7.8M | $11.3M | $6.8M | $14.0M | $11.6M | $12.9M | $10.9M | $15.2M | $14.2M | |||
| Accounts Payable Current | $766.0K | $856.0K | $2.7M | $5.9M | $7.7M | $1.5M | $4.0M | $1.8M | $1.5M | $4.6M | $5.4M | $1.9M | |||
| Restricted Cash | $1.5M | $1.5M | $1.5M | $1.5M | $1.5M | $1.5M | $1.5M | $1.5M | $1.5M | $1.5M | $1.5M | $1.5M | |||
| Property And Equipment Included In Accounts Payable And Accrued Expenses | $64.0K | $19.0K | $974.0K | $399.0K | |||||||||||
| Common Stock Value | $7.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | ||||
| Operating Lease Right Of Use Asset | $19.7M | $20.3M | $20.9M | $22.0M | $22.5M | $23.1M | $24.1M | $24.8M | $25.8M | ||||||
| Operating Lease Liability Noncurrent | $14.3M | $14.7M | $15.2M | $16.0M | $16.4M | $16.7M | $17.5M | $17.9M | $18.2M | ||||||
| Operating Lease Liability Current | $3.2M | $3.1M | $3.1M | $3.1M | $3.0M | $3.0M | $3.0M | $3.5M | $3.7M | ||||||
| Amortization And Interest Accretion Related To Operating Leases | $937.0K | -$135.0K | $37.0K | ||||||||||||
| Marketable Securities Current | $20.9M | $39.6M | $54.1M | $96.6M | $95.2M | $41.4M | |||||||||
| Deferred Offering Costs In Accounts Payable And Accrued Expenses | $0.00 | $188.0K | $766.0K | ||||||||||||
| Restricted Cash Noncurrent | $1.5M | $1.5M | $1.5M | $1.5M | |||||||||||
| Other Receivables Net Current | $3.9M | $4.2M | $4.6M |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Share Based Compensation | $10.6M | $11.5M | $7.0M | $4.8M | $1.5M |
| Payments To Acquire Property Plant And Equipment | $264.0K | $497.0K | $2.6M | $3.8M | $500.0K |
| Net Cash Provided By Used In Operating Activities | -$81.6M | -$82.4M | -$69.0M | -$59.3M | -$22.6M |
| Net Cash Provided By Used In Investing Activities | -$15.2M | -$37.7M | -$32.0M | -$3.8M | -$500.0K |
| Increase Decrease In Prepaid Expenses Other | -$1.1M | $1.3M | -$2.1M | $1.8M | $2.2M |
| Increase Decrease In Accrued Liabilities | -$3.3M | -$1.7M | $1.4M | $5.5M | $6.8M |
| Increase Decrease In Accounts Payable Trade | -$935.0K | $722.0K | -$369.0K | -$1.4M | $2.5M |
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | -$16.0K | -$62.0K | $286.0K | -$316.0K | $33.0K |
| Net Cash Provided By Used In Financing Activities | $108.0M | $88.7M | -$189.0K | $112.2M | $147.7M |
| Increase Decrease In Operating Lease Liability | -$3.1M | -$3.0M | -$1.2M | -$2.0M | |
| Proceeds From Stock Plans | $292.0K | $2.5M | $253.0K | $217.0K | |
| Proceeds From Issuance Of Common Stock | $9.9M | $114.3M | |||
| Increase Decrease In Other Receivables | -$26.0K | -$4.2M | $4.3M | ||
| Payments To Acquire Marketable Securities | $94.0M | $145.2M | $29.4M | ||
| Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities | $79.0M | $108.0M | |||
| Proceeds From Issuance Initial Public Offering | $108.1M | $76.9M | |||
| Proceeds From Warrant Exercises | $406.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 | Q1 2021 |
|---|---|---|---|---|---|
| Share Based Compensation | $3.4M | $2.0M | $1.3M | $815.0K | $188.0K |
| Payments To Acquire Property Plant And Equipment | $125.0K | $53.0K | $1.2M | $1.6M | $305.0K |
| Net Cash Provided By Used In Operating Activities | -$22.9M | -$22.5M | -$15.4M | -$12.3M | -$2.8M |
| Net Cash Provided By Used In Investing Activities | $17.1M | -$11.3M | -$1.2M | -$1.6M | -$305.0K |
| Increase Decrease In Prepaid Expenses Other | -$304.0K | -$62.0K | -$1.3M | -$282.0K | $351.0K |
| Increase Decrease In Accrued Liabilities | $2.7M | -$6.8M | $166.0K | $6.5M | $3.8M |
| Increase Decrease In Accounts Payable Trade | $943.0K | $88.0K | -$120.0K | -$1.6M | $42.0K |
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | -$7.0K | -$63.0K | $124.0K | -$137.0K | $24.0K |
| Net Cash Provided By Used In Financing Activities | $0.00 | $87.0M | $130.0K | -$18.0K | |
| Increase Decrease In Operating Lease Liability | -$758.0K | $336.0K | -$2.0M | ||
| Proceeds From Stock Plans | $0.00 | $395.0K | $130.0K | ||
| Proceeds From Issuance Of Common Stock | $0.00 | $9.9M | |||
| Increase Decrease In Other Receivables | -$21.0K | -$77.0K | |||
| Payments To Acquire Marketable Securities | $6.7M | $29.2M | |||
| Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities | $24.0M | $18.0M | |||
| Proceeds From Issuance Initial Public Offering | $0.00 | $76.9M | |||
| Proceeds From Warrant Exercises |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Diluted EPS * | -$2.12 | -$2.85 | -$3.30 | -$4.42 | -$30.27 |
| Weighted Average Number Of Shares Outstanding Basic | 42.2M | 31.6M | 23.8M | 15.6M | 901.1K |
| Weighted Average Number Of Diluted Shares Outstanding | 42.2M | 31.6M | 23.8M | 15.6M | 901.1K |
| Earnings Per Share Basic | $-2.12 | $-2.85 | $-3.30 | $-4.42 | $-30.27 |
| Preferred Stock Shares Authorized | 10.0M | 10.0M | 10.0M | 10.0M | 0.00 |
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Common Stock Shares Outstanding | 68.9M | 32.6M | 23.8M | 23.7M | 963.6K |
| Common Stock Shares Issued | 68.9M | 32.6M | 23.8M | 23.7M | 963.6K |
| Common Stock Shares Authorized | 500.0M | 500.0M | 500.0M | 500.0M | 16.0M |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$0.52 | -$0.70 | -$0.92 | -$0.66 | -$0.87 | -$0.63 | -$0.98 | -$0.82 | -$0.69 | -$0.79 | -$1.23 | -$18.94 | -$9.07 | -$6.03 | -$7.42 |
| Weighted Average Number Of Shares Outstanding Basic | 34.4M | 32.7M | 32.7M | 32.6M | 32.5M | 28.7M | 23.8M | 23.8M | 23.8M | 23.6M | 14.1M | 963.6K | 894.1K | 894.1K | |
| Weighted Average Number Of Diluted Shares Outstanding | 34.4M | 32.7M | 32.7M | 32.6M | 32.5M | 28.7M | 23.8M | 23.8M | 23.8M | 23.6M | 14.1M | 963.6K | 894.1K | 894.1K | |
| Earnings Per Share Basic | $-0.52 | $-0.70 | $-0.92 | $-0.66 | $-0.87 | $-0.63 | $-0.98 | $-0.82 | $-0.69 | $-0.79 | $-1.23 | $-18.94 | $-9.07 | $-6.03 | |
| Preferred Stock Shares Authorized | |||||||||||||||
| Preferred Stock Par Or Stated Value Per Share | |||||||||||||||
| Common Stock Shares Outstanding | |||||||||||||||
| Common Stock Shares Issued | |||||||||||||||
| Common Stock Shares Authorized | |||||||||||||||
| Common Stock Par Or Stated Value Per Share |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $10.6M | $11.5M | $7.0M | $4.8M | $1.5M |
| Investment Income Interest | $4.0M | $7.1M | $6.4M | $2.8M | |
| Depreciation | $1.4M | $1.5M | $1.2M | $493.0K | $178.0K |
| Stock Issued During Period Value Stock Options Exercised | $67.0K | $2.2M | $213.0K | $217.0K | |
| Payment Of Offering Costs | $413.0K | $511.0K | $442.0K | $2.7M | $1.4M |
| Noncash Merger Related Costs | $70.0K | $134.0K | |||
| Fair Value Adjustment Of Warrants | -$58.0K | $196.0K | |||
| Stock Issued During Period Value Employee Stock Purchase Plan | $236.0K | $252.0K | $40.0K | ||
| Stock Issued During Period Value New Issues | $110.2M | ||||
| Stock Issued During Period Value Conversion Of Convertible Securities | $165.8M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $2.4M | $2.4M | $3.4M | $3.2M | $2.9M | $2.0M | $1.9M | $1.8M | $1.3M | $1.4M | $1.2M | $815.0K | $348.0K | $329.0K | $188.0K |
| Investment Income Interest | $634.0K | $842.0K | $1.1M | $1.8M | $2.1M | $1.7M | $1.6M | $1.7M | $1.8M | $943.0K | $250.0K | $9.0K | |||
| Depreciation | $388.0K | $376.0K | $150.0K | $66.0K | $37.0K | ||||||||||
| Stock Issued During Period Value Stock Options Exercised | $27.0K | $407.0K | $1.4M | $395.0K | $85.0K | $130.0K | |||||||||
| Payment Of Offering Costs | $0.00 | $206.0K | |||||||||||||
| Noncash Merger Related Costs | $11.0K | $20.0K | |||||||||||||
| Fair Value Adjustment Of Warrants | $0.00 | -$58.0K | |||||||||||||
| Stock Issued During Period Value Employee Stock Purchase Plan | $98.0K | $149.0K | |||||||||||||
| Stock Issued During Period Value New Issues | $110.2M | $329.0K | |||||||||||||
| Stock Issued During Period Value Conversion Of Convertible Securities | $165.8M |
Most recent annual filing with the SEC: March 4, 2026
Data sourced from SEC EDGAR public filings as of August 7, 2026.